Zhang P, Guo Z, Zhong K, Li Q, Ouyang J, Chen M, Hu A, Jiao X, Zhu X, He X
Organ Transplant Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Department of Surgical Oncology, Sun Yat-sen University, Dongguan, Guangdong, People's Republic of China.
Transplant Proc. 2015 Dec;47(10):2907-15. doi: 10.1016/j.transproceed.2015.10.048.
This study aimed to document the difference of immunophenotypes in peripheral blood mononuclear cells (PBMCs) between long-term stable liver transplant recipients and recipients with acute rejection. We also sought to identify whether there is any correlation between microRNA (miRNA) expression profile and the differential immunoprofile in these 2 groups to establish a specific miRNA biomarker to identify potential liver transplant recipients.
PBMCs were isolated from 53 stable liver transplant recipients (STA group) and 15 liver transplant recipients with repeated biopsy-proven rejection episodes admitted to our hospital. Immunoprofiles were analyzed by means of flow cytometry. Analysis of miRNA expression in the PBMCs was performed by means of real-time polymerase chain reaction.
The immune profiling analysis showed increased frequency of peripheral natural killer cells and regulatory T cells in stable liver transplant recipients compared with the acute rejection recipients and healthy volunteers (P < .05). There was no significant difference in the immune cell levels (CD19(+) B cells, CD4(+) T cells, and CD8(+) T cells) in PBMCs among the transplant recipient groups and healthy control subjects. Three miRNAs, miR-18b, miR-340, and miR-106b, were up-regulated in the PBMCs of the STA recipients compared with recipients with acute rejection.
These results suggest that miR-18b, miR-340, and miR-106b, which regulate the expression of specific immunophenotypes, can be used as potential biomarkers to identify long-term stable liver transplant recipients from recipients with acute rejection.
本研究旨在记录长期稳定的肝移植受者与急性排斥反应受者外周血单个核细胞(PBMCs)免疫表型的差异。我们还试图确定这两组中微小RNA(miRNA)表达谱与免疫谱差异之间是否存在任何相关性,以建立一种特定的miRNA生物标志物来识别潜在的肝移植受者。
从53例稳定的肝移植受者(STA组)和15例我院收治的经重复活检证实有排斥反应发作的肝移植受者中分离PBMCs。通过流式细胞术分析免疫谱。通过实时聚合酶链反应对PBMCs中的miRNA表达进行分析。
免疫谱分析显示,与急性排斥反应受者和健康志愿者相比,稳定的肝移植受者外周自然杀伤细胞和调节性T细胞的频率增加(P < 0.05)。移植受者组和健康对照受试者的PBMCs中免疫细胞水平(CD19(+) B细胞、CD4(+) T细胞和CD8(+) T细胞)无显著差异。与急性排斥反应受者相比,STA受者的PBMCs中有三种miRNA,即miR-18b、miR-340和miR-106b上调。
这些结果表明,调节特定免疫表型表达的miR-18b、miR-340和miR-106b可作为潜在的生物标志物,用于从急性排斥反应受者中识别长期稳定的肝移植受者。